Chapter 3 Market Overview
- CRISPR: Genetic Editing
- Pros of Genetic Editing
- CRISPR Development Phases
- Discovery of CRISPR
- Discovery of Cas9 and PAM
- Hypothesis: Adaptive Immunity
- Adaptive Immunity
- Spacer Sequences: gRNAs
- CRISPR Acts on DNA Targets
- Cas9 Cleaves Target DNA
- tracrRNA for Cas9 Systems
- CRISPR Systems in Other Species
- Cas9-Mediated Cleavage
- CRISPR-Cas9: Genome Editing
- Market Potential
- Regulatory Framework
- U.S. Regulation and Oversight
- NIH Guidelines
- U.S. FDA
- Ethical Considerations
- Regulatory Issues
- Regulations of Human Germline Edits
- Global Regulations
- Porter's Five Forces Analysis
- Patent Analysis
- Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
- Industry Drivers
- CRISPR versus Disease
- Government Funding
- CRISPR in Other Fields
- Industry Restraints
- Alternative Technologies
- Industry Challenges
- Patent Issues
Chapter 4 Industry Structure
- Commercial Therapeutics
- Correcting Genetic Errors
- Microbes
- Healthier Food
Chapter 5 Competitive Landscape
- Cellectis
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Sangamo Therapeutics
Chapter 6 Global Market for CRISPR Technology by End User
- Academic Institutes
- Research and Development Institutes
- Pharmaceutical Companies
- Biotechnology Companies
Chapter 7 Global Market for CRISPR Technology by Application
- Cell Line Engineering
- CRISPR Plasmid
- Genetic Engineering
- GRNA Databases/Gene Libraries
- Human Stem Cells
Chapter 8 Global Market for CRISPR Technology by Region
- North America
- U.S.
- Europe
- UK
- Asia-Pacific
- China
- India
- Rest of the World
Chapter 9 Company Profiles
- Caribou Biosciences
- Crispr Therapeutics
- Editas Medicine
- Genscript
- Horizon Discovery Plc
- Integrated Dna Technologies
- Intellia Therapeutics Inc.
- Lonza Group Ltd.
- New England Biolabs Inc.
- Origene Technologies
- Precision Biosciences
- Sangamo Therapeutics Inc.
- Thermo Fisher Scientific
- Transposagenbio Biophramaceuticals (Hera Biolabs)
List of Tables
Summary Table: Global Market for CRISPR Technology, by End User, Through 2023
Table 1: Selected Monogenic Disease Details
Table 2: CRISPR Application
Table 3: Selected CAR-T/Gene-Editing Collaborations
Table 4: CRISPR Technology: Selected Companies
Table 5: CRISPR Technology: Selected Mergers and Acquisitions
Table 6: CRISPR Technology: Selected Joint Ventures
Table 7: CRISPR Technology: Recent Developments
Table 8: CRISPR Technology: Competitive Scenario
Table 9: Global Market for CRISPR Technology Used by Academic Institutes, Through 2023
Table 10: Global Market for CRISPR Technology Used by Academic Institutes, by Region, Through 2023
Table 11: Global Market for CRISPR Technology Used by R&D Institutes, Through 2023
Table 12: Global Market for CRISPR Technology Used by R&D Institutes, by Region, Through 2023
Table 13: Global Market for CRISPR Technology Used by Pharmaceutical Companies, Through 2023
Table 14: Global Market for CRISPR Technology Used by Pharmaceutical Companies, by Region, Through 2023
Table 15: Global Market for CRISPR Technology Used by Biotechnology Companies, Through 2023
Table 16: Global Market for CRISPR Technology Used by Biotechnology Companies, by Region, Through 2023
Table 17: Global Market for CRISPR Technology, by Application, Through 2023
Table 18: Global Market for CRISPR Technology in Cell Line Engineering Applications, Through 2023
Table 19: Global Market for CRISPR Technology in Cell Line Engineering Applications, by Region, Through 2023
Table 20: Global Market for CRISPR Technology in Plasmid Applications, Through 2023
Table 21: Global Market for CRISPR Technology in Plasmid Applications, by Region, Through 2023
Table 22: Global Market for CRISPR Technology in Genetic Engineering Applications, Through 2023
Table 23: Global Market for CRISPR Technology in Genetic Engineering Applications, by Region, Through 2023
Table 24: Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, Through 2023
Table 25: Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, by Region, Through 2023
Table 26: Global Market for CRISPR Technology in Human Stem Cell Applications, Through 2023
Table 27: Global Market for CRISPR Technology in Human Stem Cell Applications, by Region, Through 2023
Table 28: Global Market for CRISPR Technology, by Region, Through 2023
Table 29: North American Market for CRISPR Technology, Through 2023
Table 30: North American Market for CRISPR Technology, by End User, Through 2023
Table 31: North American Market for CRISPR Technology, by Application, Through 2023
Table 32: U.S. Market for CRISPR Technology, Through 2023
Table 33: U.S. Market for CRISPR Technology, by End User, Through 2023
Table 34: U.S. Market for CRISPR Technology, by Application, Through 2023
Table 35: European Market for CRISPR Technology, Through 2023
Table 36: European Market for CRISPR Technology, by End User, Through 2023
Table 37: European Market for CRISPR Technology, by Application, Through 2023
Table 38: UK Market for CRISPR Technology, Through 2023
Table 39: UK Market for CRISPR Technology, by End User, Through 2023
Table 40: UK Market for CRISPR Technology, by Application, Through 2023
Table 41: Asia-Pacific Market for CRISPR Technology, Through 2023
Table 42: Asia-Pacific Market for CRISPR Technology, by End User, Through 2023
Table 43: Asia-Pacific Market for CRISPR Technology, by Application, Through 2023
Table 44: Chinese Market for CRISPR Technology, Through 2023
Table 45: Chinese Market for CRISPR Technology, by End User, Through 2023
Table 46: Chinese Market for CRISPR Technology, by Application, Through 2023
Table 47: Indian Market for CRISPR Technology, Through 2023
Table 48: Indian Market for CRISPR Technology, by End User, Through 2023
Table 49: Indian Market for CRISPR Technology, by Application, Through 2023
Table 50: Rest of the World Market for CRISPR Technology, Through 2023
Table 51: Rest of the World Market for CRISPR Technology, by End User, Through 2023
Table 52: Rest of the World Market for CRISPR Technology, by Application, Through 2023
Table 53: Caribou Biosciences: Product Portfolio
Table 54: Caribou Biosciences: Recent Developments
Table 55: CRISPR Therapeutics: Product Portfolio
Table 56: CRISPR Therapeutics: Recent Developments
Table 57: Editas Medicine: Product Portfolio
Table 58: Editas Medicine: Recent Developments
Table 59: Genscript: Product Portfolio
Table 60: Genscript: Recent Developments
Table 61: Horizon Discovery: Product Portfolio
Table 62: Horizon Discovery: Recent Developments
Table 63: Integrated DNA Technologies (IDT): Product Portfolio
Table 64: Integrated DNA Technologies (IDT): Recent Developments
Table 65: Intellia Therapeutics Inc.: Product Portfolio
Table 66: Intellia Therapeutics Inc.: Recent Developments
Table 67: Lonza Group Ltd.: Product Portfolio
Table 68: Lonza Group Ltd.: Recent Developments
Table 69: New England Biolabs Inc.: Product Portfolio
Table 70: New England Biolabs Inc.: Recent Developments
Table 71: OriGene Technologies: Product Portfolio
Table 72: Precision BioSciences: Product Portfolio
Table 73: Precision BioSciences: Recent Developments
Table 74: Sangamo Therapeutics Inc.: Product Portfolio
Table 75: Sangamo Therapeutics Inc.: Recent Developments
Table 76: Thermo Fisher Scientific Inc.: Product Portfolio
Table 77: Thermo Fisher Scientific Inc.: Recent Developments
Table 78: Transposagenbio Biopharmaceuticals (Hera Biolabs): Product Portfolio
Table 79: Transposagenbio Biopharmaceuticals (Hera Biolabs): Recent Developments
List of Figures
Summary Figure: Global Market for CRISPR Technology, by End User, 2017-2023
Figure 1: Porter's Five Forces Model
Figure 2: Patent Activity on CRISPR Technology, 2008-2018
Figure 3: CRISPR Licensing Landscape
Figure 4: NIH Funding for CRISPR Research, 2014-2018
Figure 5: Global Market for CRISPR Technology, by End User, 2017-2023
Figure 6: Global Market for CRISPR Technology, by Application, 2017-2023
Figure 7: Global Market for CRISPR Technology, by Region, 2017-2023
